Brijjit Medical has filed a notice of an exempt offering of securities to raise $1,000,000.00 in New Debt Financing.
According to filings with the U.S. Securities and Exchange Commission, Brijjit Medical is raising $1,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Felmont Eaves played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Brijjit Medical
Brijjit Medical Inc., a medical device start-up, is changing the way wounds are closed and scars are prevented utilizing innovative technology with a world class team. You know that skin tension on closure sites can contribute to poor healing or scarring. The Brijjit force modulating tissue bridge is uniquely positioned to relieve tension. We think once you try it, you’ll be floored by the results. Namaste! Brijjit force modulating tissue bridge is a unique, noninvasive device that reduces tension when closing and supporting wounds. Its use may also be extended into the post-closure healing phase to continue tension reduction and improve final scar appearance so wounds can heal beautifully.
To learn more about Brijjit Medical, visit http://brijjitmedical.com/
Contact:
Felmont Eaves, Chief Executive Officer
770-485-3190
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.